高盛发表研究报告指，虽然港交所(00388.HK) 的股价因每股盈利上调及估值扩张而于本年上升约35%，但相对于近期较强劲的市场活动水平，其价值仍被低估。该行估计，中期而言，若有更多A股公司在港上市，2025财年的日均成交额将有约15%的潜在上升空间，计及有一半机会发生的可能性，上调2026至27年的日均成交预测7%及6%，料分别达2,400亿及2,580亿元。该行预期，随着更多新股上市，港交所的市值将持续扩大。
在香港上市衍生产品方面，高盛表示，推出新产品仍是ADV增长的核心。交易所已推出每周到期的指数期权及股票期权合约。
该行上调港交所2025至27财年的每股盈测2%、9%及10%，重申“买入”评级，目标价由398元调升至455元。(sl/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-30 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.